Is a high dose of Huperzine A really suitable for pretreatment against high doses of soman?

Journal of Applied Biomedicine

Volumn 7, Issue 2, 2009, Pages 93-99

  Karasová, Jana Ždárová ^a   Bajgar, Jiří ^a   Novotný, Ladislav ^b   Kuča, Kamil ^a,b,c  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c J E PURKINJE UNIVERSITY   (Czech Republic)

Author keywords

Acetylcholinesterase; Brain; Huperzine A; Nerve agent; Pretreatment; Soman

Indexed keywords

ACETYLCHOLINESTERASE; HUPERZINE A; SOMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BLOOD BRAIN BARRIER; BRAIN REGION; CONTROLLED STUDY; DIAPHRAGM; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INHIBITION; FASCICULATION; INTOXICATION; LACRIMATION; MALE; MORTALITY; NONHUMAN; PONTOMEDULLAR AREA; PROPHYLAXIS; RAT; SALIVATION; SINGLE DRUG DOSE; TIME; TREMOR;

ANIMALIA;

EID: 67650658883     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.32725/jab.2009.009     Document Type: Article

References (25)

1. Aldridge WN: Organophosphorus compounds and carbamates, and their reactions with esterases. Br Med Bull 25:239-239, 1969.
2. Andersson RD, Harris LW, Woodard CL, Lennox WI: The effects of pyridostigmine pretreatment on oxime efficacy against intoxication by soman and VX in rats. Drug Chem Toxicol 15:285-294, 1992.
3. Ashani Y, Peggins J, Doctor BP: Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun 184:719-726, 1992.
4. Bajgar J: Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151-216, 2004.
5. Bajgar J, Fusek J, Patočka J, Hrdina V: Protective effect of 9-amino-7-methoxy-1,2,3,4-tetrahydro-acridine against O-ethyl-S-(2-dimethylaminoethyl) methyl-phosphono-thiolate in vivo. Arch Toxicol 54:163-166, 1983.
6. Bajgar J, Fusek J, Kuea K, Bartošová L, Jun D: Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini Rev Med Chem 7:461-466, 2007a.
7. Bajgar J, Hájek P, Karasová J, Slizová D, Krs O, Kuča K, Jun D, Fusek J, Čapek L: Inhibition of acetylcholinesterase in different structures of the rat brain following soman intoxication pretreated with huperzine A. Int J Mol Sci 8:1165-1175, 2007b.
8. Cheng DH, Tang XC: Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol Biochem Behav 60:377-386, 1998.
9. Eckert S, Eyer P, Worek F: Reversible inhibition of acetylcholinesterase by carbamates or Huperzine A increases residual activity of the enzyme upon soman challenge. Toxicology 233:180-186, 2007.
10. Ellman GL, Coutney DK, Andres V, Featherstone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95, 1961.
11. Filliat P, Foquin A, Lallement G: Effects of chronic administration of huperzine A on memory in guinea pigs. Drug Chem Toxicol 25:9-24, 2002.
12. Fusek J: Tacrin and its analogues, antidotes against psychotomimetics with anticholinergic effect (in Czech). Voj Zdrav Listy 46:21-27, 1977.
13. Gunwald J, Raveh L, Doctor BP, Ashani Y: Huperzine A as a pretreatment candidate drug against nerve agent toxicity. Life Sci 54:991-997, 1994.
14. Holmstedt B: Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol Rev 11:567-688, 1959.
15. Koelle GB: Protection of cholinesterase against irreversible inactivation by DFP in vitro. J Pharmacol Exp Ther 88:323-327, 1946.
16. Koster R: Synergisms and antagonisms between physostigmine and diisopropyl fluorophosphates in cats. J Pharmacol Exp Ther 88:39-46, 1946.
17. Kubín L, Fenik V: Pontine cholinergic mechanisms and their impact on respiratory regulation. Respir Physiol Neurobiol 143:235-249, 2004.
18. Lallement G, Veyret J, Masqueliez C, Aubriot S, Burckhart MF, Baubichon D: Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality. Fundam Clin Pharmacol 11:387-394, 1997.
19. Lallement G, Demoncheaux JP, Foquin A, Baubichon D, Galonnier M, Claren&on D, Dorandeu F: Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity. Drug Chem Toxicol 25:309-320, 2002a.
20. Lallement G, Baille V, Baubichon D, Carpentier P, Collombet JM, Filliat P, Foquin A, Four E, Masquelies C, Testylier G, Tonduli L, Dorandeu F: Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 23:1-5, 2002b.
21. Patočka J: Huperzine A - An interesting anticholinesterase compound from the Chinese herbal medicine. Acta Med (Hradec Králové) 41:155-157, 1998.
22. Patočka J, Jun D, Bajgar J, Kuča K: Prophylaxis against nerve agent intoxications. Def Sci J 56:775-784, 2006.
23. Tondulli LS, Testylier G, Masqueliez C, Lallement G, Monmaur P: Effects of huperzine used as pre-treatment against soman-induced seizures. Neurotoxicology 22:29-37, 2001.
24. Zangara A: The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacol Biochem Behav 75:675-686, 2003.
25. Zhao Q, Tang XC: Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Eur J Pharmacol 455:101-107, 2002.